Half-life revisited: implication in clinical trials and bioavailability/bioequivalence evaluation
- PMID: 1865346
- DOI: 10.1002/jps.2600800427
Half-life revisited: implication in clinical trials and bioavailability/bioequivalence evaluation
Comment in
-
Estimation of absorption rate constant in a one-compartment model with the profile of the bioavailable dose eliminated as a function of multiples of half-life.J Pharm Sci. 1993 Dec;82(12):1298-300. doi: 10.1002/jps.2600821226. J Pharm Sci. 1993. PMID: 8308718 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
